Drug Trial Radar · NCT07482787
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Jul 21, 2026
Primary completion
May 17, 2027
Study completion Jun 17, 2027
Sponsor
- Lead sponsor
- Paradigm TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 28 days, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The upcoming trial is for EB patients is a topically applied whole-body treatment of patients with either Simplex, RDEB or Junctional (nH) ages 1 month to 12 years old at study entry. There are only 4 site visits by patients with minimal assessments over a 2-month period, and patients completing this study will have the ability to continue receiving SD-101-6.0 at home in an open-label extension study. The drug product and placebo require no special preparation or storage conditions (room temperature).
Conditions
- Epidermolysis Bullosa (EB)
Interventions
SD-101 Dermal Cream (6%)Drug
SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.
Vehicle (SD-101 0%)Drug
A white, crystalline powder that is formulated within an odorless, soft, white cream base. It contains no allantoin, only excipients.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Target wound closureTime frame: 1 month
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Mission Dermatology
Rancho Santa Margarita, California · Recruiting
Stanford University School of Medicine Dermatology Department
Redwood City, California · Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Medical University of South Carolina Department of Dermatology and Dermatologic Surgery
Charleston, South Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.